FDA clearance for SPECTRALIS Anterior Segment Module
Heidelberg Engineering GmbH has announced that the United States Food and Drug Administration (FDA) has granted clearance for the new SPECTRALIS Anterior Segment Module (ASM).
“The SPECTRALIS Anterior Segment Module paves the way towards digital gonioscopy,†said Sanjay Asrani MD, associate professor of ophthalmology, Duke University Eye Center. “Glaucoma surgeons will further benefit from the enhanced depth imaging (EDI) OCT capabilities of SPECTRALIS when assessing filtering blebs and anterior chamber angles.â€
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.